UAE Allows Patented API Imports to Reduce Local Generic Delay

UAE Allows Patented API Imports to Reduce Local Generic Delay
The UAE says it will allow generic drug manufacturers to import active ingredients of patented drugs to encourage local industry growth.

Following a meeting last week between the UAE Ministry of Health (MoH) and local pharma manufacturers, Dr. Amin Al Amiri - Assistant Undersecretary for Medical Practices and Licensing in the UAE – announced factories will be allowed to import active substances for the purposes of research, development and bioequivalence studies before the patent has expired.

Al Amiri told the Gulf News​ this will benefit both the consumer and the UAE’s pharma industry. “Generic market entry is often delayed because a manufacturer has to invest up to 18-24 months for clinical study and research before marketing the generic drug.”

Such a move will allow generic versions of drugs to be immediately available once patent has expired from the 15 companies at the meeting who currently make the 940 drugs produced locally. 

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars